Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Rev. bras. hematol. hemoter ; 24(2): 137-138, abr.-jun. 2002. ilus
Artículo en Portugués | LILACS | ID: lil-365260

RESUMEN

Acute leukemia following treatment with Iodine131 is a rare event. The possible carcinogenic effect of Iodine131 is still not clear and a large series of cases did not show an increased incidence of cancer. A case of AML t(8;21), three years after Iodine131 treatment for hyperthyroidism, is reported. Secondary AML with t(8;21) is described following exposure to drugs that target topoisomerase II and radiotherapy. The controversial potential of Iodine131 as a leukemogenic agent and the fact that t(8;21) is also found in de-novo AML, emphasize the problem in establishing a relationship between these events although this potential can not be ruled out.


Asunto(s)
Leucemia Mieloide Aguda , Hipertiroidismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA